ConductScience.org, home

Paper23905680

Quinazolin-4-one derivatives as selective histone deacetylase-6 inhibitors for the treatment of Alzheimer's disease.

Yu CW and 3 others. J Med Chem, 2013. Cited by 79 papers, by iCite.

Cite this record

ConductScience Library. Quinazolin-4-one derivatives as selective histone deacetylase-6 inhibitors for the treatment of Alzheimer's disease. Papers, record 23905680. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23905680

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Quinazolin-4-one derivatives as selective histone deacetylase-6 inhibitors for the treatment of Alzheimer's disease.
PubMed
Journal
J Med Chem
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
79
iCite
Relative citation ratio, by iCite
2.76
iCite
Revised in PubMed
2017-11-16
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yu CWChao-Wu
2Chang PTPei-Teh
3Hsin LWLing-Wei
4Chern JWJi-Wang

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Histone Deacetylase InhibitorsMajor topic
Histone DeacetylasesMajor topic
QuinazolinonesMajor topic
Animals
Histone Deacetylase 6
Humans
Magnetic Resonance Spectroscopy
PC12 Cells
Rats
Spectrometry, Mass, Electrospray Ionization

Source PubMed

Download CSV of topics

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.

PMIDTitleJournalYearIn PapersSource
42395723A chemoenzymatic synthesis of amide-containing quinazolin-4(3H)-one derivatives.RSC Adv2026https://conductscience.org/library/papers/42395723PubMed
41940800GV-001, An Oral Available Histone Deacetylase 6 Inhibitor for the Treatment of Autosomal Dominant Polycystic Kidney Disease.J Med Chem2026https://conductscience.org/library/papers/41940800PubMed
40530721Histone Deacetylase Inhibition in Alzheimer's Disease: Molecular Mechanisms, Therapeutic Potential, and Future Perspectives.Curr Top Med Chem2025https://conductscience.org/library/papers/40530721PubMed
39219429Cinnamic Acid Derivatives: Recent Discoveries and Development Strategies for Alzheimer's Disease.Mini Rev Med Chem2025https://conductscience.org/library/papers/39219429PubMed
38859778Insight in Quinazoline-based HDAC Inhibitors as Anti-cancer Agents.Mini Rev Med Chem2024https://conductscience.org/library/papers/38859778PubMed
37190931Synthesis and biological evaluation of C-4 substituted phenoxazine-bearing hydroxamic acids with potent class II histone deacetylase inhibitory activities.J Enzyme Inhib Med Chem2023https://conductscience.org/library/papers/37190931PubMed
36036883HDAC6: A unique HDAC family member as a cancer target.Cell Oncol (Dordr)2022https://conductscience.org/library/papers/36036883PubMed
35424458Metal-free synthesis of 1,4-benzodiazepines and quinazolinones from hexafluoroisopropyl 2-aminobenzoates at room temperature.RSC Adv2021https://conductscience.org/library/papers/35424458PubMed
35408604Target Design of Novel Histone Deacetylase 6 Selective Inhibitors with 2-Mercaptoquinazolinone as the Cap Moiety.Molecules2022https://conductscience.org/library/papers/35408604PubMed
32565717Methods for Hydroxamic Acid Synthesis.Curr Org Chem2019https://conductscience.org/library/papers/32565717PubMed
32013157HDAC6-an Emerging Target Against Chronic Myeloid Leukemia?Cancers (Basel)2020https://conductscience.org/library/papers/32013157PubMed
32012896The Effect of Protein-Rich Extract from Bombyx Batryticatus against Glutamate-Damaged PC12 Cells Via Regulating γ-Aminobutyric Acid Signaling Pathway.Molecules2020https://conductscience.org/library/papers/32012896PubMed
31788622Continuous Activity Assay for HDAC11 Enabling Reevaluation of HDAC Inhibitors.ACS Omega2019https://conductscience.org/library/papers/31788622PubMed
30645113Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors.J Med Chem2019https://conductscience.org/library/papers/30645113PubMed
30557385Cholinesterase inhibitor rivastigmine enhances nerve growth factor-induced neurite outgrowth in PC12 cells via sigma-1 and sigma-2 receptors.PLoS One2018https://conductscience.org/library/papers/30557385PubMed
30511829Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome.ACS Chem Neurosci2019https://conductscience.org/library/papers/30511829PubMed
30332838Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer's and Parkinson's Diseases.Int J Mol Sci2018https://conductscience.org/library/papers/30332838PubMed
30261020Novel histone deacetylase inhibitors and embryo aggregation enhance cloned embryo development and ES cell derivation in pigs.PLoS One2018https://conductscience.org/library/papers/30261020PubMed
29869029Dynamic localization of α-tubulin acetyltransferase ATAT1 through the cell cycle in human fibroblastic KD cells.Med Mol Morphol2018https://conductscience.org/library/papers/29869029PubMed
29844403The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.Cell Death Dis2018https://conductscience.org/library/papers/29844403PubMed

See all 29 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYP4F34051PubTator's text mininghttps://conductscience.org/library/genes/4051NCBI Gene
HDAC610013PubTator's text mininghttps://conductscience.org/library/genes/10013NCBI Gene
HDAC99734PubTator's text mininghttps://conductscience.org/library/genes/9734NCBI Gene
TUBA1B10376PubTator's text mininghttps://conductscience.org/library/genes/10376NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23905680

GET https://conductscience.org/api/papers/v1/23905680/cited_by?page=2